The role of ADRB2 gene polymorphisms in malignancies

被引：15
作者：
Wang, Yaqian [1 ]
Jiang, Shujuan [1 ,2 ,3 ]
机构：
[1] Shandong Univ, Shandong Prov Hosp, Cheeloo Coll Med, Dept Resp & Crit Care Med, Jingwu Rd 324, Jinan 250021, Shandong, Peoples R China
[2] Shandong First Med Univ, Shandong Prov Hosp, Dept Resp & Crit Care Med, Jinan 250021, Shandong, Peoples R China
[3] Shandong Key Lab Infect Resp Dis, Jinan 250021, Shandong, Peoples R China
来源：
MOLECULAR BIOLOGY REPORTS | 2021年 / 48卷 / 03期
关键词：
ADRB2; Malignancy; Single nucleotide polymorphism; β (2)-Adrenergic receptor; BETA-2-ADRENERGIC RECEPTOR GENE; CELL LUNG-CANCER; SINGLE NUCLEOTIDE POLYMORPHISMS; 5' LEADER CISTRON; BETA-BLOCKERS; BREAST-CANCER; PROMOTER POLYMORPHISMS; ANTAGONIST PROPRANOLOL; SMOOTH-MUSCLE; KAPPA-B;
D O I：
10.1007/s11033-021-06250-y
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Beta-2-adrenergic receptor is a member of the G protein-coupled receptor superfamily, which is highly expressed in most malignancies. There is increasing evidence showing that beta-2-adrenergic receptors are associated with carcinogenesis, proliferation, immune regulation, invasion, angiogenesis, clinical prognosis and treatment resistance in malignancies. Polymorphisms of the ADRB2 gene have been confirmed to be associated with transcriptional activity, mRNA translation, and beta-2-adrenergic receptor expression and sensitivity. This review discusses clinically relevant examples of single nucleotide polymorphisms of ADRB2 in malignancies and the effects of these polymorphisms on cancer susceptibility, prognosis and treatment response of cancer patients.
引用
收藏
页码：2741 / 2749
页数：9
相关论文
共 50 条
  • [31] ADRB2 G-G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity
    Connor, Avonne
    Baumgartner, Richard N.
    Kerber, Richard A.
    O'Brien, Elizabeth
    Rai, Shesh N.
    Wolff, Roger K.
    Slattery, Martha L.
    Giuliano, Anna R.
    Risendal, Betsy C.
    Byers, Tim E.
    Baumgartner, Kathy B.
    CANCER CAUSES & CONTROL, 2012, 23 (10) : 1653 - 1663
  • [32] The role of non-HLA gene polymorphisms in graft-versus-host disease
    Takami, Akiyoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (03) : 309 - 318
  • [33] The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions
    Berardi, Rossana
    Goteri, Gaia
    Pagliaretta, Silvia
    Paolucci, Vittorio
    Morgese, Francesca
    Conti, Alessandro
    Refai, Majed
    Pompili, Cecilia
    Duranti, Claudia
    Marcantognini, Giulia
    Savini, Agnese
    Caramanti, Miriam
    Rinaldi, Silvia
    Torniai, Mariangela
    Santoni, Matteo
    Zizzi, Antonio
    Mazzanti, Paola
    Onofri, Azzurra
    Ricci, Giulia
    Scarpelli, Marina
    JOURNAL OF THORACIC DISEASE, 2020, 12 (12) : 7245 - 7256
  • [34] Loss of Hypermethylated in Cancer 1 (HIC1) in Breast Cancer Cells Contributes to Stress-induced Migration and Invasion through β-2 Adrenergic Receptor (ADRB2) Misregulation
    Boulay, Gaylor
    Malaquin, Nicolas
    Loison, Ingrid
    Foveau, Benedicte
    Van Rechem, Capucine
    Rood, Brian R.
    Pourtier, Albin
    Leprince, Dominique
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (08) : 5379 - 5389
  • [35] The Role of Interleukin-4 and 13 Gene Polymorphisms in Allergic Rhinitis: A Case Control Study
    Shirkani, Afshin
    Mansouri, Atena
    Hosseini, Reza Farid
    Azad, Farahzad Jabbari
    Mahmoudian, Reihaneh Alsadat
    Montazer, Mehdi
    Samimi, Abdolreza
    Momtazi-Borojeni, Amir Abbas
    Abbaszadegan, Mohammad Reza
    Gholamin, Mehran
    REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 8 (02): : 111 - 118
  • [36] Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms
    Gupta, M.
    Chauhan, C.
    Bhatnagar, P.
    Gupta, S.
    Grover, S.
    Singh, P. K.
    Purushottam, M.
    Mukherjee, O.
    Jain, S.
    Brahmachari, S. K.
    Kukreti, R.
    PHARMACOGENOMICS, 2009, 10 (02) : 277 - 291
  • [37] Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer
    Schueler, Susanne
    Lattrich, Claus
    Skrzypczak, Maciej
    Fehm, Tanja
    Ortmann, Olaf
    Treeck, Oliver
    GENE, 2014, 546 (02) : 283 - 287
  • [38] Gene polymorphisms predict toxicity to neoadjuvant therapy in patients with rectal cancer
    Duldulao, Marjun P.
    Lee, Wendy
    Nelson, Rebecca A.
    Ho, Joyce
    Le, Maithao
    Chen, Zhenbin
    Li, Wenyan
    Kim, Joseph
    Garcia-Aguilar, Julio
    CANCER, 2013, 119 (05) : 1106 - 1112
  • [39] Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility
    Treeck, Oliver
    Elemenler, Esma
    Kriener, Christina
    Horn, Felicitas
    Springwald, Anette
    Hartmann, Arndt
    Ortmann, Olaf
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2009, 114 (3-5) : 207 - 211
  • [40] Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India
    Kapahi, Ruhi
    Guleria, Kamlesh
    Sambyal, Vasudha
    Manjari, Mridu
    Sudan, Meena
    Uppal, Manjit Singh
    Singh, Neeti Rajan
    TUMOR BIOLOGY, 2014, 35 (11) : 11171 - 11181
12345